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and oral antibiotics were prescribed. Three months later, the patient
felt pain, and oral antibiotics were prescribed a second time. However,
the pain did not improve, and amass of 2 cm in diameter was surgically
resected. The surrounding hardened tissues were removed with curet-
tage, but some hard tissue, few millimeters in thickness, remained
(Fig. 1A). The obtained specimen revealed that the tumor was com-
posed of slender spindle cells with eosinophilic cytoplasm, sharing
both features of ﬁbroblasts and smoothmuscle cells (Fig. 2A–B). Immu-Introduction
kinase (ALK), or desmin, was negative.
Based on these ﬁndings, the patient was diagnosed with LGMS. ASarcomas arising in the vulva are rare and are often misdiagnosed
clinically as Bartholin gland cysts (Curtin et al., 1995). Low-grade
myoﬁbroblastic sarcomas (LGMSs), although rare, typically occur in
the head and neck region (Fisher, 2004); they have been reported
in the vulva in only 1 case report (Roth et al., 2004).
Local recurrence of LGMS, an indolent tumor, occurs in 47% of
patients 17 to 46 months after the initial excision (Meng et al., 2007).
In the previously reported case, a 5 × 3 cm tumor was resected by
wide local excision, but the follow-up time was only 14 months. Here,
we report a second case of LGMS of the vulva, with long-term disease-
free survival after radical local excision (RLE).Case
A 24-year-old nulligravida presented with a nodule on her left
labia minora. She had felt discomfort while sitting approximately
1 month earlier and had noticed the tumor; however, at the time of
presentation, she did not feel any pain. Physical examination revealed
a subcutaneous, movable, non-tender mass of 2 × 3 cm in diameter.).
Inc. Open access under CC BY license.nohistochemistry showed thatmost spindle cellswere immunoreactive
for α-smooth muscle actin (α-SMA) and vimentin and had an MIB-1
index of 10% (Fig. 2C–D). In contrast, immunostaining for other
markers, such as CD34, S-100, c-kit, HMB-45, anaplastic lymphoma
computed tomography scan of the abdomen and pelvis revealed no
evidence of metastasis. The residual tumor could not be detected by
palpation. RLE was performed to remove the surgical scar with a
2-cm margin, and the underlying fascia was resected. During surgery,
free margins were conﬁrmed by the examination of multiple frozen
sections. The operation was completed using a combination of skin
andmucosal ﬂaps (Fig. 1B-D). The obtained specimen included residual
tumor cells inﬁltrating into the surrounding tissue, although tumor-free
margins, 2 cm in width and depth, were conﬁrmed. The patient was
followed-up without postoperative radiation or adjuvant therapy. She
has been without evidence of recurrence for 72 months since RLE.Discussion
Myoﬁbroblasts, ﬁrst described in granulation tissue 40 years ago, are
mesenchymal spindle cells that share ultrastructural features of both
ﬁbroblasts and smooth-muscle cells. Occasionally, myoﬁbroblasts under-
go tumorigenic transformation and become malignant (Mentzel et al.,
1998). A LGMS is a rare malignant tumor withmyoﬁbroblastic differenti-
ation (Fisher, 2004) that is classiﬁed as a distinct entity according to the
World Health Organization classiﬁcation of soft tissue tumors. Histopath-
ologically, LGMS is characterized by fusiform tumor cells that are arranged
in complicated, sheet-like or storiform pattern and show diffuse, inﬁltra-
tive growth (Mentzel et al., 1998). Immunohistochemically, tumor cells
stain positive for at least one of the myogenic markers (α-SMA, desmin,
and muscle-speciﬁc actin) (Meng et al., 2007; Mentzel et al., 1998;
Montgomery et al., 2001).
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Fig. 1. (A) After local excision of the primary surgery. Arrow indicates the left labia minora. Arrowhead indicates the introitus with hymen. (B) Defect after radical local excision.
Arrowhead indicates the introitus with hymen. Arrow indicates the left levator ani muscle. (C) A combination of a labia major advancement ﬂap, a rhomboid ﬂap from inner thigh,
and a mucosal ﬂap from contralateral side of the vaginal vestibule was designed to cover the defect. (D) Reconstruction of the defect was completed by placement of a subcutaneous
drain. Arrow indicates a Foley catheter passed through the urethra and into the bladder.
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cells with myoﬁbroblastic differentiation and an MIB-1 index of 10%,
indicative of low proliferation. The tumor cells were immunopositive
for α-SMA and vimentin and negative for S-100, CD34, c-kit, and
HMB-45. A diagnosis of inﬂammatory myoﬁbroblastic tumor was
ruled out due to the specimen's high cellularity, morphologically uni-
form appearance, and less inﬁltrative lymphocytes or plasma cells.
Based on these ﬁndings, the specimenwas diagnosed as LGMS. A recent
study has shown that LGMS tumor cells were also negative for ALK (Qiu
et al., 2008).
The clinical course of LGMS is relatively indolent (Meng et al., 2007).
LGMS has inﬁltrative characteristics, and some cases have shown
lesions with compression of the surrounding tissues (Montgomery
et al., 2001). The recurrence rate in a large series was reported as 40%
(24 out of 60 patients), and distant recurrence was rare (Meng et al.,
2007; Mentzel et al., 1998; Montgomery et al., 2001; Qiu et al., 2008;
Agaimy et al., 2008). Adjuvant chemotherapy or radiation therapy was
conducted in some patients, but the therapeutic effect was unclear
(Meng et al., 2007; Mentzel et al., 1998; Montgomery et al., 2001). In
the previously reported case of LGMS of the vulva, the mass was easily
shelled out from the subcutaneous tissue during the ﬁrst surgery with
a wide local excision, and the margins were conﬁrmed negative patho-
logically (Roth et al., 2004). Aartsen et al. originally proposed the impor-
tance of adequatemargin resectionwith local excision for the treatment
of sarcoma of the vulva and suggested that the actual extent of the neo-
plasmwas inevitably greater than what was initially apparent (Aartsen
and Albus-Lutter, 1994). Although the width of the margins was notspeciﬁcally deﬁned, 2 cm has been considered sufﬁcient by some
authors (Aartsen and Albus-Lutter, 1994; Ulutin et al., 2003). In this
case, the mass was slightly adhesive to the surrounding tissue, and en
bloc resection was not completed during the primary surgery. Hence,
RLE was conducted after diagnosis of LGMS.
Studies have reported that vulvar sarcomamainly metastasizes via
the hematogenous route, and groin dissection has been performed in
few cases reported in the literature (Aartsen and Albus-Lutter, 1994;
Ulutin et al., 2003). Aartsen EJ et al. performed groin dissection in 18 of
47 patients with vulvar sarcoma, but groin metastases were observed
only in 5 patients (Aartsen and Albus-Lutter, 1994). Mentzel et al.
reported 3 cases of recurrence among 18 LGMS cases: 2 patients devel-
oped local recurrence and 1 patient had multiple metastatic disease
(Mentzel et al., 1998). Montgomery reviewed 13 patients, and of 7 pa-
tients with recurrence, only 1 showed distant metastasis to the lungs
(Montgomery et al., 2001). Qiu et al. reported 3 cases of local recur-
rence, including 1 case of metastasis to the tongue, among 8 cases
(Qiu et al., 2008). Thus, LGMS rarely shows lymphogenous metastasis
and the beneﬁt of therapeutic inguinal lymphadenectomy is minimal.
Therefore, we did not perform inguinal lymphadenectomy in the
current case.
Here, we report a rare case of LGMS of the vulva that was success-
fully treated with RLE and reconstruction. Because low-grade sarco-
ma or LGMS of the vulva is extremely rare, the deﬁnitive surgical
procedure for inﬁltrative LGMS has not yet been determined. This
case provides a useful reference to aid in the decision-making pro-
cess for similar cases.
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Fig. 2. Immunohistochemistry of the tumor specimen. (A) The tumor comprised intersecting fascicles of spindle cells (hematoxylin and eosin [H&E], ×100). (B) Most tumor cells
had eosinophilic cytoplasm with mild atypical nuclei (H&E, × 400). (C) The cytoplasm of the tumor cells were diffusely stained with antibody to α-smooth muscle actin (α-SMA)
(×400). (D) Arrows point to Ki-67 immunohistochemical reactivity, seen in 10% of the tumor cells (×400).
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